Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.26298
Abstract: Asthma guidelines have recommended continuing treatment with biologics during coronavirus disease 2019 (COVID‐19) pandemic. However, a continuation of treatment with biologics in patients with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been little investigated. read more here.
Keywords: asthmatic patients; safety biologics; severe asthmatic; patients sars ... See more keywords